DelistingAug 10, 2026, 06:08 AM
Arcadia Biosciences Receives Nasdaq Delisting Notice
AI Summary
Arcadia Biosciences, Inc. received a notice from Nasdaq on August 4, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share for continued listing. The company's common stock traded below this threshold for 30 consecutive business days. Arcadia has an initial 180-calendar-day period, until February 1, 2027, to regain compliance, and plans to evaluate options, including a reverse stock split.
Key Highlights
- Received Nasdaq notice on August 4, 2026, for non-compliance.
- Failed minimum bid price requirement of $1.00 per share.
- Stock traded below $1.00 for 30 consecutive business days.
- Initial compliance period is 180 days, until February 1, 2027.
- Must maintain $1.00 bid price for 10 consecutive business days.
- Company will consider options, including a reverse stock split.
Price Impact
More from RKDA